Assessing the risk of venous thromboembolism and identifying barriers to thromboprophylaxis in the hospitalized patient

Journal of Hospital Medicine

Volumn 4, Issue SUPPL. 2, 2009, Pages

  McKean, Sylvia C ^a   Deitelzweig, Steven B ^b   Sasahara, Arthur ^a   Michota, Franklin ^c   Jacobson, Anne ^d   Dollar, Whitney Stevens ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Cleveland Clinic ^*

Author keywords

Prophylaxis barriers; Risk assessment; Venous thromboembolism

Indexed keywords

AMITRIPTYLINE; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; CLOZAPINE; CONTRACEPTIVE AGENT; ESTROGEN; HEPARIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OLANZAPINE; RECOMBINANT ERYTHROPOIETIN; RISPERIDONE;

AGE; CANCER PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL PATIENT; HUMAN; INFECTION; INJURY; LIFESTYLE; OBESITY; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM;

AGE FACTORS; HOSPITALIZATION; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; THROMBOLYTIC THERAPY; VENOUS THROMBOEMBOLISM;

EID: 77950316047     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.587     Document Type: Review

References (62)

1. Anderson FA Jr, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol. 2007;82(9):777-782.
2. Stein PD, Beemath A, Olson RE. Trends in the incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients. Am J Cardiol. 2005;95(12):1525-1526.
3. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines. 8th ed. Chest. 2008;133(6 suppl):381S-453S.
4. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation. 1996;93(12)2212-2245.
5. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151(5):933-938.
6. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125(1):1-7.
7. O'Brien JA, Caro JJ. Direct medical cost of managing deep vein thrombosis according to the occurrence of complications. Pharmacoeconomics. 2002;20(9):603-615.
8. Spyropoulos AC, Lin J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J Manag Care Pharm. 2007;13(6):475-486.
9. Piazza G, Seddighzadeh A, Goldhaber SZ. Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent. Chest. 2007;132(2):554-561.
10. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 suppl 1):I9-I16.
11. Alikhan R, Cohen AT, Combe S, et al. Risk factors for VTE in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med. 2004;164(9):963-968.
12. Cohen AT, Tapson VF, Bergmann JF, et al.; ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387-394.
13. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809-815.
14. Heinemann LA, Dinger JC. Range of published estimates of venous thromboembolism incidence in young women. Contraception. 2007;75(5):328-336.
15. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The risk of recurrent venous thromboembolism in men and women. N Engl J Med. 2004;350(25):2558-2563.
16. Beemath A, Stein PD, Skaf E, et al. Risk of venous thromboembolism in patients hospitalized with heart failure. Am J Cardiol. 2006;98(6):793-795.
17. Stein PD, Beemath A, Meyers FA, et al. Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease. J Cardiovasc Med. 2007;8(4):253-257.
18. Stein PD, Beemath A, Meyers FA, et al. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med. 2006;119(1):60-68.
19. Ambrus JL, Ambrus CM, Mink IB, et al. Causes of death in cancer patients. J Med. 1975;6(1):61-64.
20. Fernandez PM, Rickles FR. Tissue factor and angiogenesis in cancer. Curr Opin Hematol. 2002;9(5):401-406.
21. Fotopoulou C, duBois A, Karavas AN, et al. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel- containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. J Clin Oncol. 2008;26(16):2683-2689.
22. Gerber DE, Segal JB, Levy MY, Kane J, Jones RJ, Streiff MB. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention. Blood. 2008;112(3):504-510.
23. Bennett CL, Silver SM, Djulbegovic B, et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA. 2008;299(8):914-924.
24. Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg. 2006;243(1):89-95.
25. Goldhaber SZ. Pulmonary embolism in thrombolysis: a clarion call for international collaboration. J Am Coll Cardiol. 1992;19:246-247.
26. Ageno W, Becattini C, Brighton T, et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117(1): 93-102.
27. Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study. J Thromb Haemost. 2008;6(11):1851-1857.
28. Borch KH, Brækkan SK, Mathiesen EB, et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome - the Tromsø study. J Thromb Haemost. 2009;7(5):739-745.
29. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93(2):259-262.
30. Alikhan R, Cohen AT, Combe, et al. Prevention of venous thromboembolism in medical patients with enoxaparin; a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis. 2003;14:341-348.
31. Howell MD, Geraci JM, Knowlton AA. Congestive heart failure and outpatient risk of venous thromboembolism: a retrospective, case-control study. J Clin Epidemiol. 2001;54(8):810-816.
32. Cohen AT, Davidson BL, Gallus AS, et al.; ARTEMIS Investigators. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006;332(7537):325-329.
33. Gardlund B. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group. Lancet. 1996;347(9012):1357-1361.
34. Copur AS, Smith PR, Gomez V, et al. HIV infection is a risk factor for venous thromboembolism. AIDS Patient Care STDS. 2002;16(5):205-209.
35. Eichinger S, Hron G, Bialonczyk C, et al. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med. 2008;168(15):1678- 1683.
36. Rathbun S. Venous thromboembolism in women. Vasc Med. 2008;13(3):255-266.
37. James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005;193(1):216-219.
38. Shetty R, Seddighzadeh A, Piazza G, et al. Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination. J Thromb Thrombolysis. 2008;26(1):35-40.
39. Meissner MH, Chandler WL, Elliott JS. Venous thromboembolism in trauma: a local manifestation of systemic hypercoagulability? J Trauma. 2003;54(2):224-231.
40. Kazory A, Ducloux D. Acquired hypercoagulable state in renal transplant recipients. Thromb Haemost. 2004;91(4):646-654.
41. Seddighzadeh A, Zurawska U, Shetty R, Goldhaber SZ. Venous thromboembolism in patients undergoing surgery: low rates of prophylaxis and high rates of filter insertion. Thromb Haemost. 2007;98(6):1220-1225.
42. Shackford SR, Rogers FB, Terrien CM, Bouchard P, Ratliff J, Zubis R. A 10-year analysis of venous thromboembolism on the surgical service: the effect of practice guidelines for prophylaxis. Surgery. 2008;144(1):3-11.
43. Noboa S, Le Gal G, Lacut K, et al.; EDITH Collaborative Study Group. Family history as a risk factor for venous thromboembolism. Thromb Res. 2008;122(5):624-629.
44. Canonico M, Bouaziz E, Carcaillon L, et al.; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women. J Clin Endocrinol Metab. 2008;93(8):3082-3087.
45. Lindqvist PG, Epstein E, Olsson H. The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study. Br J Haematol. 2009;144(2):234-240.
46. Steffen LM, Folsom AR, Cushman M, Jacobs DR Jr, Rosamond WD. Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Circulation. 2007;115(2):188-195.
47. Sare GM, Gray LJ, Bath PM. Association between hormone replacement therapy and subsequent arterial and venous vascular events: a metaanalysis. Eur Heart J. 2008;29(16):2031-2041.
48. Cole JA, Norman H, Doherty M, Walker AM. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol. 2007;109(2 Pt 1):339-346.
49. Borras L, Eytan A, de Timary P, Constant EL, Huguelet P, Hermans C. Pulmonary thromboembolism associated with olanzapine and risperidone. J Emerg Med. 2008;35(2):159-161.
50. Hägg S, Bate A, Stahl M, Spigset O. Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions. Drug Saf. 2008;31(8):685-694.
51. Paciullo CA. Evaluating the association between clozapine and venous thromboembolism. Am J Health Syst Pharm. 2008;65(19):1825-1829.
52. Jick SS, Li L. Antidepressant drug use and risk of venous thromboembolism. Pharmacotherapy. 2008;28(2):144-150.
53. Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm. 2007;64(1):69-76.
54. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients. Chest. 2007;132:936-945.
55. Jois-Bilowich P, Michota F, Bartholomew JR, et al. Adhere Scientific Advisory Committee and Investigators. Venous thromboembolism prophylaxis in hospitalized heart failure patients. J Card Fail. 2008;14(2):127-132.
56. Amin A, Spyropolous A, Dobesh P, et al. Are hospitals following guidelines for VTE Prevention? The Venous Thromboembolism Study to Assess the Rate of Thromboprophylaxis. Presented at the 50th Annual Meeting of the American College of Hematology, San Francisco, CA, December 6-9, 2008. Abstract 1286.
57. Tooher R, Middleton P, Pham C, et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg. 2005;241(3):397-415.
58. Howard DP. A need for a simplified approach to venous thromboembolism prophylaxis in acute medical inpatients. Int J Clin Pract. 2007;61(2):336-340.
59. Borris LC. Barriers to the optimal use of anticoagulants after orthopaedic surgery. Arch Orthop Trauma Surg. 2008 (Published online Oct, 8.). [http://dx.doi.org/DOI 10.1007/s00402-008-0765-9]
60. Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: Insights from the FRONTLINE survey. Oncologist. 2003;8:381-388.
61. Deheinzelin D, Braga AL, Martins LC, et al. Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil. J Thromb Haemost. 2006;4(6):1266-1270.
62. Vats V, Nutescu EA, Theobald JC, Wojtynek JE, Schumock GT. Survey of hospitals for guidelines, policies, and protocols for anticoagulants. Am J Health Syst Pharm. 2007;64(11):1203-1208.